
Writer
Kirti Kumbhar
M. Pharm QA
Kirti Kumbhar is an M.Pharm graduate with experience in Quality Assurance at Lupin Limited and a strong interest in clinical research, regulatory affairs, and Trial Master File (TMF) management. She has developed knowledge of regulatory documentation, quality systems, compliance, and healthcare research through her professional experience. Passionate about clinical development and continuous learning, Kirti is committed to supporting high-quality healthcare documentation, regulatory excellence, and research-driven healthcare advancements.
109
Articles written or reviewed
About Kirti
Kirti Kumbhar (M. Pharm QA) is a writer at Pharmacally, with 109 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Kirti Kumbhar
Clinical TrialsKylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Effect for 48 Weeks
Clinical TrialsRoche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Patients at Two Years
Clinical TrialsApazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome
Drugs Safety AlertFDA Adds Boxed Warning to Injectafer Over Serious Hypophosphatemia Risk
FoodKetogenic Diet Linked to Better Liver Health and Blood Sugar Control After Weight Loss
Health TidingsAZD5462 Shows Early Effects in Phase IIb Heart Failure Trial
New Drug ApprovalFDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermatomyositis
Clinical TrialsSpyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls Short of Monotherapy Bar
New Drug ApprovalFDA Approves Tivicay PD for HIV-1 Treatment in Babies from BirthOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala